Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 8,252 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 6,293 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 6,847 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 7,365 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 9,305 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 12,427 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 8,613 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 6,036 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 7,905 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER◆ | 2,989 | — | — | — | Open the original filing on SEC.gov |
| Nov 2 | SUPN | Supernus Pharmaceuticals,… | JOTHER | 124,119 | — | — | -100.0% | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | DTOISS◆ | 4,475 | — | — | — | Open the original filing on SEC.gov |
| Feb 24 | SUPN | Supernus Pharmaceuticals,… | AGRANT | 4,475 | — | — | +3.7% | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 4,977 | — | — | — | Open the original filing on SEC.gov |
| Feb 18 | SUPN | Supernus Pharmaceuticals,… | AGRANT◆ | 2,989 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 21, 2025 | SUPN | Supernus Pharmaceuticals,… | MEXER | 15,000 | $12.98 | $194.7K | +14.3% | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,200 | $51.55 | $61.9K | -1.1% | Open the original filing on SEC.gov |
| Oct 9, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 23,800 | $50.73 | $1.2M | -18.4% | Open the original filing on SEC.gov |
| Aug 27, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 3,588 | $45.01 | $161.5K | -2.7% | Open the original filing on SEC.gov |
| Aug 25, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,000 | $45.00 | $45K | -0.7% | Open the original filing on SEC.gov |
| Aug 22, 2025 | SUPN | Supernus Pharmaceuticals,… | SSELL◷ | 1,412 | $45.00 | $63.5K | -1.0% | Open the original filing on SEC.gov |